Drug
Sela 070
Sela 070: highest development phase Phase 1, developed by Selecta Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Selecta Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| SELA-070 NCT03148925 | Phase 1 | Smoking Cessation |
Latest
No recent events.
Follow Sela 070 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.